Alzheimer’s disease biomarkers in animal models: closing the translational gap

Por Sabbagh, Jonathan J, Kinney, Jefferson W, Cummings, Jeffrey L
Publicado em 2013

Chronic ketamine produces altered distribution of parvalbumin-positive cells in the hippocampus of adult rats

Por Sabbagh, Jonathan J., Murtishaw, Andrew S., Bolton, Monica M., Heaney, Chelcie F., Langhardt, Michael, Kinney, Jefferson W.
Publicado em 2013

A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus

Por Lu, Xiaoying, Barr, Alasdair M., Kinney, Jefferson W., Sanna, Pietro, Conti, Bruno, Behrens, M. Margarita, Bartfai, Tamas
Publicado em 2005

Baclofen administration alters fear extinction and GABAergic protein levels

Por Heaney, Chelcie F., Bolton, Monica M., Murtishaw, Andrew S., Sabbagh, Jonathan J., Magcalas, Christy M., Kinney, Jefferson W.
Publicado em 2012

Deficits in emotional learning and memory in an animal model of schizophrenia

Por Bolton, Monica M., Heaney, Chelcie F., Sabbagh, Jonathan J., Murtishaw, Andrew S., Magcalas, Christy M., Kinney, Jefferson W.
Publicado em 2012

Effects of fatigue on balance in individuals with Parkinson disease: influence of medication and brain-derived neurotrophic factor genotype

Por Baer, Michael, Klemetson, Bradley, Scott, Diana, Murtishaw, Andrew S., Navalta, James W., Kinney, Jefferson W., Landers, Merrill R.
Publicado no J Neurol Phys Ther (2018)

Deficits in Trace Cued Fear Conditioning in Galanin-Treated Rats and Galanin-Overexpressing Transgenic Mice

Por Kinney, Jefferson W., Starosta, Grzegorz, Holmes, Andrew, Wrenn, Craige C., Yang, Rebecca J., Harris, Ashley P., Long, Katharine C., Crawley, Jacqueline N.
Publicado em 2002

Impairment of Memory Consolidation by Galanin Correlates with In-Vivo Inhibition of Both LTP and CREB Phosphorylation

Por Kinney, Jefferson W., Sanchez-Alavez, Manuel, Barr, Alasdair M., Criado, Jose R., Crawley, Jacqueline N., Behrens, M. Margarita, Henriksen, Steven J., Bartfai, Tamas
Publicado em 2009

Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer’s disease

Por Cummings, Jeffrey L., Zhong, Kate, Kinney, Jefferson W., Heaney, Chelcie, Moll-Tudla, Joanne, Joshi, Abhinay, Pontecorvo, Michael, Devous, Michael, Tang, Anne, Bena, James
Publicado no Alzheimers Res Ther (2016)